# Conduct Hit-to-Lead Progression Studies on Interventional Agents: Identification of Anti-HIV Lead Compounds

> **NIH NIH N01** · SOUTHERN RESEARCH INSTITUTE · 2020 · $749,998

## Abstract

n Vitro Testing Resource for HIV Therapeutics and Topical Microbicides: The development and introduction of new therapeutics and topical microbicides against HIV remains a high public health priority. To assist in filling these public health gaps, the NIAID supports preclinical development of promising therapeutic and topical microbicide candidates that emerge from academia, the private sector, or other sources. This contract provides in vitro testing, in standard and HTS formats, and conducts preclinical development studies to identify promising anti‐HIV therapeutics and topical microbicides.

## Key facts

- **NIH application ID:** 10267147
- **Project number:** 272201400010I-0-759302000005-1
- **Recipient organization:** SOUTHERN RESEARCH INSTITUTE
- **Principal Investigator:** SUSAN SCHADER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $749,998
- **Award type:** —
- **Project period:** 2020-09-21 → 2021-09-20

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10267147

## Citation

> US National Institutes of Health, RePORTER application 10267147, Conduct Hit-to-Lead Progression Studies on Interventional Agents: Identification of Anti-HIV Lead Compounds (272201400010I-0-759302000005-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10267147. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*